| HOME >> MEDICINE >> TECHNOLOGY |
VisEn Introduces ProSense® 750 FAST and Neutrophil ElastaseTM
680 FAST 55
Bayer Works on Development of MR Contrast Agents for Breast
Cancer Diagnosis 55
Lantheus Medical Imaging Introduces ABLAVAR™ MRA Imaging Agent 56
VisEn Introduces Cat B 680 FAST™ Imaging Agent 56
VisEn Medical Introduces GastroSense 750 Fluorescence Imaging
Agent 56
VisEn Medical Unveils VivoTag® 645 Red Fluorescent Dye 57
VisEn Medical Launches VivoTag® 680 XL Fluorescent Dye 57
AMAG Pharmaceuticals Unveils Superparamagnetic Iron Oxide
Nanopaticles 57
MabCure Unveils Monoclonal Antibodies 57
VisEn Medical Introduces ReninSense680TM FAST 58
VisEn Medical Introduces New VivoTag® 800 and OsteoSense®
Imaging Agents 58
VisEn Medical Introduces Annexin-Vivo 750 Imaging Agent 58
VisEn Introduces New Fluorescence Molecular Imaging Agent,
IntegriSense™ 750 59
Bayer to Launch Primovist™ and Nexavar™ in Japan 59
Sanochemia Unveils MR-Lux® 60
VisEn Medical Introduces New Fluorescence in Vivo Imaging
Agent, IntegriSense 60
Bayer to Unleash Radiology Management System 61
Bayer to Unveil Pre-Filled Contrast-Medium Cartridges for MRI 61
10. RECENT INDUSTRY ACTIVITY 62
University of Montana Receives Patents for Two New Brain
Imaging Agents 62
Eli Lilly Acquires Avid Radiopharmaceuticals 62
GE Global Research Secures Multi-Year NIH Grant to Develop
Nerve Imaging Agent and Imaging System 62
Agfa Healthcare Snaps Insight Agents 62
Nordion to Divest MDS Nordion S.A. 63
Sofie Biosciences Secures Funds for Research on Molecular PET
Imaging Agents 63
Aposense Signs Collaboration Agreement With Roche 63
University of Washington to Collaborate with Cardinal Health
for Advancement of
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |